United States Biotechnology & Medical Research

Bright Minds Biosciences Inc (DRUG)

Track

Track

Bright Minds Biosciences experienced two recent insider trading transactions, resulting in a net negative value of approximately $326,593. While Director Ian McDonald purchased shares worth $99,256, Director Nils Bottler sold holdings valued at $425,850. These activities follow the company's May 2026 results financiers, where the firm outperformed earnings expectations by 13.49 percent.
Ticker: DRUG Exchange: CNX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bright Minds Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
McDonald, Ian Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
81.87
Quantity 92,186 +20.5%
Value US$348,642
3.0
Bottler, Nils Director of Issuer Non-Executive Director
Transaction date
Sale
Price
216.32
Quantity 36,747
Value US$2,697,858
Vasilkevich, Alex Senior Officer of Issuer Officer
Transaction date
Sale
Price
57.76
Quantity 12,876 -20.7%
Value CA$2,763,915
Vasilkevich, Alex Senior Officer of Issuer Officer
Transaction date
Sale
Price
121.74
Quantity 500 -2.5%
Value CA$60,870
Cormorant Asset Management LP 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
89.50
Quantity 109,331 -10.3%
Value US$9,785,124
2.9
Pedersen, Jan Torleif Director of Issuer Non-Executive Director
Transaction date
Sale
Price
50.40
Quantity 2,400 -4.0%
Value CA$120,960
2.9
Pedersen, Jan Torleif Director of Issuer Non-Executive Director
Transaction date
Sale
Price
56.47
Quantity 25,000 -41.7%
Value CA$1,411,795
3.0
Bottler, Nils Director of Issuer Non-Executive Director
Transaction date
Sale
Price
40.84
Quantity 16,000 -76.2%
Value US$653,408
3.2
Cheung, Ryan Senior Officer of Issuer Officer
Transaction date
Sale
Price
71.08
Quantity 100
Value CA$7,108
3.2
Cheung, Ryan Senior Officer of Issuer Officer
Transaction date
Sale
Price
79.98
Quantity 4,900 -98.0%
Value CA$391,902
3.0
Bottler, Nils Director of Issuer Non-Executive Director
Transaction date
Sale
Price
77.93
Quantity 400 -7.4%
Value CA$31,172
1.4
Fryzuk, Jeremy Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
21.70
Quantity 188,940 +4099.4%
Value US$4,099,998
3.0
Bottler, Nils Director of Issuer Non-Executive Director
Transaction date
Sale
Price
49.80
Quantity 5,000 -48.1%
Value US$248,975
1.4
Fryzuk, Jeremy Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
21.70
Quantity 4,609
Value US$100,015
1.5
McDonald, Ian Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Sale
Price
40.28
Quantity 300,000 -30.8%
Value CA$12,084,000
1.4
Fryzuk, Jeremy Director of Issuer Non-Executive Director
Transaction date
Sale
Price
40.29
Quantity 2,400 -9.1%
Value CA$96,696
1.4
Fryzuk, Jeremy Director of Issuer Non-Executive Director
Transaction date
Sale
Price
6.23
Quantity 3,600 -60.0%
Value CA$22,428
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-12 B Purchase
1.5
McDonald, Ian

Director of Issuer, Senior Officer of Issuer

Executive Director
92,186 +20.5%
81.87
US$348,642 		92,186 +20.5% 81.87 US$348,642
2026-06-09 2026-06-01 S Sale
3.0
Bottler, Nils

Director of Issuer

Non-Executive Director
36,747
216.32
US$2,697,858 		36,747 216.32 US$2,697,858
2026-04-30 2026-04-30 S Sale
Vasilkevich, Alex

Senior Officer of Issuer

Officer
12,876 -20.7%
57.76
CA$2,763,915 		12,876 -20.7% 57.76 CA$2,763,915
2026-04-30 2026-04-30 S Sale
Vasilkevich, Alex

Senior Officer of Issuer

Officer
500 -2.5%
121.74
CA$60,870 		500 -2.5% 121.74 CA$60,870
2026-06-19 2026-04-28 S Sale
Cormorant Asset Management LP

10% Security Holder of Issuer

Large shareholder
109,331 -10.3%
89.50
US$9,785,124 		109,331 -10.3% 89.50 US$9,785,124
2026-04-30 2026-04-28 S Sale
3.7
Cormorant Asset Management, LP

Former 10% Owner
109,331 -10.3%
89.50
US$9,785,124 		109,331 -10.3% 89.50 US$9,785,124
2025-04-06 2025-04-02 S Sale
2.9
Pedersen, Jan Torleif

Director of Issuer

Non-Executive Director
2,400 -4.0%
50.40
CA$120,960 		2,400 -4.0% 50.40 CA$120,960
2024-12-10 2024-12-06 S Sale
2.9
Pedersen, Jan Torleif

Director of Issuer

Non-Executive Director
25,000 -41.7%
56.47
CA$1,411,795 		25,000 -41.7% 56.47 CA$1,411,795
2024-11-13 2024-11-12 S Sale
3.0
Bottler, Nils

Director of Issuer

Non-Executive Director
16,000 -76.2%
40.84
US$653,408 		16,000 -76.2% 40.84 US$653,408
2024-11-11 2024-11-08 S Sale
3.2
Cheung, Ryan

Senior Officer of Issuer

Officer
100
71.08
CA$7,108 		100 71.08 CA$7,108
2024-11-11 2024-11-07 S Sale
3.2
Cheung, Ryan

Senior Officer of Issuer

Officer
4,900 -98.0%
79.98
CA$391,902 		4,900 -98.0% 79.98 CA$391,902
2024-11-08 2024-11-05 S Sale
3.0
Bottler, Nils

Director of Issuer

Non-Executive Director
400 -7.4%
77.93
CA$31,172 		400 -7.4% 77.93 CA$31,172
2024-11-08 2024-11-04 B Purchase
1.4
Fryzuk, Jeremy

Director of Issuer

Non-Executive Director
188,940 +4099.4%
21.70
US$4,099,998 		188,940 +4099.4% 21.70 US$4,099,998
2024-11-08 2024-11-04 S Sale
3.0
Bottler, Nils

Director of Issuer

Non-Executive Director
5,000 -48.1%
49.80
US$248,975 		5,000 -48.1% 49.80 US$248,975
2024-11-07 2024-11-04 B Purchase
1.4
Fryzuk, Jeremy

Director of Issuer

Non-Executive Director
4,609
21.70
US$100,015 		4,609 21.70 US$100,015
2024-11-06 2024-11-04 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
184,331 +21.1%
21.70
US$3,999,983 		184,331 +21.1% 21.70 US$3,999,983
2024-10-26 2024-10-16 S Sale
1.5
McDonald, Ian

Director of Issuer, Senior Officer of Issuer

Executive Director
300,000 -30.8%
40.28
CA$12,084,000 		300,000 -30.8% 40.28 CA$12,084,000
2024-10-17 2024-10-16 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
3,107 +0.4%
25.22
US$78,365 		3,107 +0.4% 25.22 US$78,365
2024-10-17 2024-10-16 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
7,150 +0.8%
24.03
US$171,814 		7,150 +0.8% 24.03 US$171,814
2024-10-17 2024-10-16 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
39,743 +4.8%
23.22
US$922,634 		39,743 +4.8% 23.22 US$922,634
2024-10-23 2024-10-15 S Sale
1.4
Fryzuk, Jeremy

Director of Issuer

Non-Executive Director
2,400 -9.1%
40.29
CA$96,696 		2,400 -9.1% 40.29 CA$96,696
2024-10-17 2024-10-15 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
4,609 +0.6%
12.35
US$56,927 		4,609 +0.6% 12.35 US$56,927
2024-10-17 2024-10-15 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
19,169 +2.4%
11.72
US$224,601 		19,169 +2.4% 11.72 US$224,601
2024-10-17 2024-10-15 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
2,700 +0.3%
9.26
US$25,008 		2,700 +0.3% 9.26 US$25,008
2024-10-17 2024-10-15 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
2,600 +0.3%
8.80
US$22,890 		2,600 +0.3% 8.80 US$22,890
2024-10-17 2024-10-15 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
8,900 +1.1%
7.31
US$65,016 		8,900 +1.1% 7.31 US$65,016
2024-10-17 2024-10-15 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
33,343 +4.4%
6.42
US$214,219 		33,343 +4.4% 6.42 US$214,219
2024-10-17 2024-10-15 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
63,173 +9.1%
5.92
US$374,237 		63,173 +9.1% 5.92 US$374,237
2024-10-17 2024-10-15 B Purchase
3.7
Cormorant Asset Management, LP
Large shareholder
238,097 +52.6%
4.53
US$1,078,675 		238,097 +52.6% 4.53 US$1,078,675
2023-08-09 2023-08-08 S Sale
1.4
Fryzuk, Jeremy

Director of Issuer

Non-Executive Director
3,600 -60.0%
6.23
CA$22,428 		3,600 -60.0% 6.23 CA$22,428
Explore more

More insider trading research around Bright Minds Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America